<DOC>
	<DOCNO>NCT03094273</DOCNO>
	<brief_summary>Non-interventional study evaluate utility remove Dysplastic Nevi define 2 mm margin .</brief_summary>
	<brief_title>Prospective Study 2 mm Margins Biopsy Dysplastic Nevi</brief_title>
	<detailed_description>This prospective , observational study evaluate utility remove Dysplastic Nevi ( DN ) define 2 mm margin . This non-interventional study observe pathology result follow standard care biopsy . Principal Investigator ( PI ) hypothesize majority lesion remove technique margin free nevus cell examination histopathological section . Hence , pathologists suggest additional excision perform remove residual nevus . PI also hypothesize biopsy site follow time , rate nevus recurrence low , investigator would remove majority , lesion time initial biopsy .</detailed_description>
	<mesh_term>Nevus</mesh_term>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Dysplastic Nevus Syndrome</mesh_term>
	<criteria>All patent see practice study physician eligible participate study . Patients must 18 year age . Patients able provide inform consent . Patient must lesion differential diagnosis include DN study dermatologist deems appropriate perform saucerization biopsy . Patients le 18 year age . Patients unable provide inform consent . Lesions saucerization biopsy impractical judgment study dermatologist base certain clinical factor ( e.g . patient anticoagulation therapy , lesion size and/or anatomic location ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Melanocytic neoplasm</keyword>
	<keyword>Biopsy</keyword>
	<keyword>Saucerization biopsy</keyword>
	<keyword>Skin lesion</keyword>
</DOC>